Search

Author/Creator Farbstein, Motti

1. CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open‐Label, Dose‐Escalation Study. (8th January 2012)

Authors:
Stemmer, Salomon M.; Benjaminov, Ofer; Medalia, Gal; Ciuraru, Noab B.; Silverman, Michael H.; Bar‐Yehuda, Sara; Fishman, Sari; Harpaz, Zivit; Farbstein, Motti; Cohen, Shira; Patoka, Renana; Singer, Barak; Kerns, William D.; Fishman, Pnina
Journal:
Oncologist
Issue:
Volume 18:Number 1(2013)
Page Start:
25
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Editorial: targeting aberrant hepatic inflammation for treatment of non‐alcoholic steatohepatitis—authors' reply. Issue 4 (28th January 2022)

Authors:
Safadi, Rifaat; Braun, Marius; Francis, Adi; Milgrom, Yael; Massarwa, Muhammad; Hakimian, David; Hazou, Wadi; Issachar, Assaf; Harpaz, Zivit; Farbstein, Motti; Itzhak, Inbal; Lev‐Cohain, Naama; Bareket‐Samish, Avital; Silverman, Michael H.; Fishman, Pnina
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 55:Issue 4(2022)
Page Start:
485
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Randomised clinical trial: A phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis. Issue 11 (20th October 2021)

Authors:
Safadi, Rifaat; Braun, Marius; Francis, Adi; Milgrom, Yael; Massarwa, Muhammad; Hakimian, David; Hazou, Wadi; Issachar, Assaf; Harpaz, Zivit; Farbstein, Motti; Itzhak, Inbal; Lev‐Cohain, Naama; Bareket‐Samish, Avital; Silverman, Michael H.; Fishman, Pnina
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 54:Issue 11/12(2021)
Page Start:
1405
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗